KR20240070705A - 펩타이드 화합물 및 계면활성제를 포함하는 조성물 - Google Patents

펩타이드 화합물 및 계면활성제를 포함하는 조성물 Download PDF

Info

Publication number
KR20240070705A
KR20240070705A KR1020247015265A KR20247015265A KR20240070705A KR 20240070705 A KR20240070705 A KR 20240070705A KR 1020247015265 A KR1020247015265 A KR 1020247015265A KR 20247015265 A KR20247015265 A KR 20247015265A KR 20240070705 A KR20240070705 A KR 20240070705A
Authority
KR
South Korea
Prior art keywords
less
compound
peptide compound
composition
absorption
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247015265A
Other languages
English (en)
Korean (ko)
Inventor
신이치 나카에
류스케 다카노
헝민 탕
유지 사쿠라이
Original Assignee
추가이 세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 추가이 세이야쿠 가부시키가이샤 filed Critical 추가이 세이야쿠 가부시키가이샤
Publication of KR20240070705A publication Critical patent/KR20240070705A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Detergent Compositions (AREA)
  • Medicinal Preparation (AREA)
KR1020247015265A 2021-10-13 2022-10-12 펩타이드 화합물 및 계면활성제를 포함하는 조성물 Pending KR20240070705A (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2021167912 2021-10-13
JPJP-P-2021-167912 2021-10-13
JP2022075833 2022-05-02
JPJP-P-2022-075833 2022-05-02
EP22192611 2022-08-29
EP22192611.6 2022-08-29
PCT/JP2022/038128 WO2023063376A1 (ja) 2021-10-13 2022-10-12 ペプチド化合物及び界面活性剤を含む組成物

Publications (1)

Publication Number Publication Date
KR20240070705A true KR20240070705A (ko) 2024-05-21

Family

ID=83546822

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247015265A Pending KR20240070705A (ko) 2021-10-13 2022-10-12 펩타이드 화합물 및 계면활성제를 포함하는 조성물

Country Status (7)

Country Link
US (1) US20250302912A1 (https=)
EP (2) EP4609875A3 (https=)
JP (1) JPWO2023063376A1 (https=)
KR (1) KR20240070705A (https=)
DK (1) DK4166133T3 (https=)
TW (1) TW202330014A (https=)
WO (1) WO2023063376A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI787670B (zh) 2011-12-28 2022-12-21 日商中外製藥股份有限公司 具有環狀部之胜肽化合物及其醫藥組成物
WO2024219446A1 (ja) * 2023-04-19 2024-10-24 中外製薬株式会社 環状ペプチド化合物及び界面活性剤を含む組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009518437A (ja) 2005-12-09 2009-05-07 ユニジーン・ラボラトリーズ・インコーポレーテッド 速効性経口ペプチド医薬品
WO2013100132A1 (ja) 2011-12-28 2013-07-04 中外製薬株式会社 ペプチド化合物の環化方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH679277A5 (https=) * 1989-02-09 1992-01-31 Sandoz Ag
US5912014A (en) * 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
NZ328751A (en) * 1997-09-16 1999-01-28 Bernard Charles Sherman Solid medicament containing an anionic surfactant and cyclosporin
TW200409644A (en) * 2002-12-04 2004-06-16 Bio Max Inc Improved carrier system for cyclosporin pharmaceutical compositions
AU2012271691A1 (en) * 2011-06-14 2014-01-16 Stealth Peptides International, Inc. Aromatic-cationic peptides and uses of same
CN104853749A (zh) * 2012-09-17 2015-08-19 塔瑞克斯制药有限公司 血管紧张素的口服制剂
DE102013219920A1 (de) * 2013-10-01 2015-04-02 Henkel Ag & Co. Kgaa leistungsgesteigerte Haarbehandlungsmittel
WO2016004067A1 (en) * 2014-06-30 2016-01-07 Stealth Biotherapeutics Corp Aromatic-cationic peptide formulations, compositions and methods of use
JP7232758B2 (ja) * 2017-06-09 2023-03-06 中外製薬株式会社 膜透過性の高い環状ペプチド化合物、及びこれを含むライブラリ
WO2018225851A1 (ja) * 2017-06-09 2018-12-13 中外製薬株式会社 Ｎ－置換アミノ酸を含むペプチドの合成方法
PE20221323A1 (es) * 2019-11-07 2022-09-09 Chugai Pharmaceutical Co Ltd Compuesto de peptidos ciclicos que tiene accion inhibidora de kras

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009518437A (ja) 2005-12-09 2009-05-07 ユニジーン・ラボラトリーズ・インコーポレーテッド 速効性経口ペプチド医薬品
WO2013100132A1 (ja) 2011-12-28 2013-07-04 中外製薬株式会社 ペプチド化合物の環化方法

Also Published As

Publication number Publication date
TW202330014A (zh) 2023-08-01
WO2023063376A1 (ja) 2023-04-20
EP4609875A3 (en) 2025-12-03
DK4166133T3 (da) 2025-09-01
JPWO2023063376A1 (https=) 2023-04-20
US20250302912A1 (en) 2025-10-02
EP4166133B1 (en) 2025-07-23
EP4166133A1 (en) 2023-04-19
EP4609875A2 (en) 2025-09-03

Similar Documents

Publication Publication Date Title
JP2023011754A (ja) Ｈｉｖウイルス感染症の予防的または治療的処置に有用な治療用化合物
FI97524C (fi) Menetelmä syklosporiinia sisältävän farmaseuttisen koostumuksen valmistamiseksi
WO2024219446A1 (ja) 環状ペプチド化合物及び界面活性剤を含む組成物
KR20240070705A (ko) 펩타이드 화합물 및 계면활성제를 포함하는 조성물
BRPI0813733A2 (pt) composto com atividade inibidora de hcv, sua composição farmacêutica e seu uso.
KR20250002095A (ko) 계면활성제와 병용하기 위한 펩타이드 화합물을 포함하는 조성물
AU2010244857A1 (en) High penetration prodrug compositions of peptides and peptide-related compounds
UA120508C2 (uk) Комплекси сиролімусу і його похідних, спосіб їх отримання і фармацевтичні композиції, що містять зазначені комплекси
JPH0419208B2 (https=)
WO2023190283A1 (ja) ポリオキシエチレン構造を含む油性成分を含有する化合物製剤
WO2001058489A1 (en) Preventives/remedies for postoperative stress
HK40111890A (zh) 包含肽化合物和表面活性剂的组合物
CN118176012A (zh) 包含肽化合物和表面活性剂的组合物
HK40111891A (zh) 用於与表面活性剂联用的包含肽化合物的组合物
US12582694B2 (en) Compounds and methods for inhibiting protozoan parasites
EP4582092A1 (en) Composition containing peptide, surfactant, and polymer
CN116234539A (zh) 血栓素受体拮抗剂调配物
HK40111865A (zh) 含有包含聚氧乙烯结构的油性成分的化合物制剂
JP4767256B2 (ja) 安定化したロイコトリエンｂ４（ｌｔｂ４）剤の医薬製剤
HK40126562A (zh) 含有环肽化合物和表面活性剂的组合物
AU625688B2 (en) Method of using aryl- or heteroaryl-1-alkyl-pyrrole-2- carboxylic acid compounds in the treatment of interleukin-1 mediated conditions
WO2023150648A3 (en) Pharmaceutical compositions, and preparation and methods of use thereof
KR20170078970A (ko) 사이클로스포린을 포함하는 약학 조성물
EA046628B1 (ru) Терапевтические соединения, их составы и применения

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20240508

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20241121

Comment text: Request for Examination of Application